Image

Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)

Recruiting
16 - 99 years of age
Both
Phase N/A

Powered by AI

Overview

To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy

Description

To develop and train a Convolutional Neural Network to detect and characterize disease severity in inflammatory bowel disease during endoscopy. This initiative will inevitably establish a high-quality large image database. Our secondary study aims are therefore to use the images we collect to advance the field of deep learning and computer aided diagnosis in inflammatory bowel disease by establishing an image database. This will involve developing a framework combining deep learning and computer vision algorithms. The ultimate aim is to use the image database to produce high impact research outcomes and training resources leading to an improvement in the quality of endoscopy performed, reduce inter-observer variability in disease assessment and a reduction in missed bowel cancer rates and associated mortality.

Eligibility

Inclusion Criteria:

  • • Any adult patient aged 16 years or older who has consented to undergo endoscopic investigation where images are captured as part of routine clinical care.

Exclusion Criteria:

  • • Any patient under the age of 16
    • Patients who are unable to give informed consent to undergo endoscopic investigation or those who do not wish their pseudo-anonymised images to be used

Study details

Inflammatory Bowel Disease 1

NCT04867408

Hull University Teaching Hospitals NHS Trust

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.